Dechra Pharmaceuticals PLC is an England-based business involved in the development and marketing of veterinary products. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

The Company sells pharmaceuticals – mainly for dogs, cats, equine and food producing animals; products include Vetoryl for Cushing’s disease in dogs and Felimazole for hyperthyroidism in cats. It is organised into two divisions: European Pharmaceuticals and US Pharmaceuticals.

Type:                     Public

Traded as:           LSE: DPH

Industry:              Pharmaceuticals

Founded:            1997

Headquarters:   Northwich, United Kingdom

Website:              www.dechra.com